Strategy

Nanogen's strategy is to assemble companies, products and technologies necessary to become a leader in advanced diagnostics. Key elements of our strategy include:

Expanding Commercial Applications. We are expanding commercial applications for our platform technology in the medical disease diagnostics market by exploiting the increasing availability of genetic information and its relationship to human disease. We are also leveraging our technology in clinical research and related markets to build a recurring stream of revenue from the sale of disposable cartridges and reagents. We believe that widespread market penetration of our instruments and devices will promote sustained demand for our consumables. Other market segments, such as pharmaceuticals, forensics and biowarfare agent detection also offer opportunity for our technologies.

Acquiring Products to Expand Revenues. In addition to its internal development programs, we seek opportunities to expand our portfolio of products by acquisition, corporate merger or in-licensing deals. As our product line grows, we will be able to offer customers a breadth of tools and subsequently, our revenue base and shareholder value are expected to increase.

Establishing Strategic Collaborations. By entering into collaborations, we can expand applications of our technology platform, access novel biomarkers and accelerate the commercialization of products. We pursue collaborations in various forms, including research and development agreements, licensing agreements and joint ventures. These collaborations permit integration of our and our partners' technologies and resources, while allowing us to pursue diagnostics, drug discovery and genomics opportunities outside the scope of these collaborations. For more information about our alliances, click here.

Developing Advanced Technologies and Point-of-Care Applications. In the long term, we plan to develop sample-to-answer systems which integrate otherwise time-consuming and labor-intensive sample preparation procedures on the disposable cartridge through the use of active microelectronics and nanotechnology. The availability of this lab-on-a-chip technology would fulfill a substantial unmet need in both academic research and commercial sectors.